BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7673611)

  • 1. Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole in clinical studies.
    Lamouliatte H
    J Clin Gastroenterol; 1995; 20 Suppl 1():S28-31. PubMed ID: 7673611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens.
    Schwartz H; Krause R; Sahba B; Haber M; Weissfeld A; Rose P; Siepman N; Freston J
    Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
    Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
    Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study).
    Di Mario F; Battaglia F; Dal Bò N; Leandro G; Benedetti E; Bottona E; Caroli A; Costan-Biedo F; De Bastiani R; Germanà B; Andrea Grassi S; Madia D; Marcon V; Marin R; Monica F; Olivieri P; Orzes N; Pilotto A; Ronzani G; Saggioro A; Tafner G
    Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
    Kawano S; Murakami M; Saita H; Tsuji S
    J Gastroenterol; 1996 Nov; 31 Suppl 9():41-3. PubMed ID: 8959517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
    Harford W; Lanza F; Arora A; Graham D; Haber M; Weissfeld A; Rose P; Siepman N
    Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer.
    Fanti L; Ieri R; Mezzi G; Testoni PA; Passaretti S; Guslandi M
    J Clin Gastroenterol; 2001 Jan; 32(1):45-8. PubMed ID: 11154169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
    Buzás György M; Székely E; Illyés G; Széles I
    Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lansoprazole on Helicobacter pylori.
    Lamouliatte H
    Clin Ther; 1993; 15 Suppl B():32-6. PubMed ID: 8205593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication.
    Wheeldon TU; Granström M; Hoang TT; Phuncarg DC; Nilsson LE; Sörberg M
    Aliment Pharmacol Ther; 2004 Jun; 19(12):1315-21. PubMed ID: 15191514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori?
    Güliter S; Keleş H; Ozkurt ZN; Cengiz DU; Kolukisa E
    Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole versus lansoprazole plus amoxicillin treatment for eradication of Helicobacter pylori in patients with gastric ulcer.
    Sugiyama T; Hisano K; Ochiai T; Fujita N; Kobayashi T; Yabana T; Kurokawa I; Yachi A
    J Clin Gastroenterol; 1995; 20 Suppl 2():S104-6. PubMed ID: 7594322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
    Sito E; Konturek PC; Bielański W; Kwiecień N; Konturek SJ; Baniukiewicz A; Jedynak M; Gabryelewicz A; Hahn EG
    J Physiol Pharmacol; 1996 Mar; 47(1):221-8. PubMed ID: 8777303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of lansoprazole in eradication of Helicobacter pylori.
    Takimoto T; Ido K; Taniguchi Y; Satoh K; Saifuku K; Kihira K; Yoshida Y; Kimura K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S121-4. PubMed ID: 7594327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential value of lansoprazole in Helicobacter pylori eradication.
    Axon AT
    J Clin Gastroenterol; 1995; 20 Suppl 1():S43-7. PubMed ID: 7673614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori.
    Fennerty MB; Kovacs TO; Krause R; Haber M; Weissfeld A; Siepman N; Rose P
    Arch Intern Med; 1998 Aug 10-24; 158(15):1651-6. PubMed ID: 9701099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
    Iwasaki A
    Nihon Rinsho; 1999 Jan; 57(1):127-33. PubMed ID: 10036949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
    Murakami K; Sato R; Okimoto T; Nasu M; Fujioka T; Kodama M; Kagawa J; Sato S; Abe H; Arita T
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1933-8. PubMed ID: 12390102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial.
    Chey WD; Fisher L; Elta GH; Barnett JL; Nostrant T; DelValle J; Hasler WL; Scheiman JM
    Am J Gastroenterol; 1997 Sep; 92(9):1483-6. PubMed ID: 9317068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.